Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs. Under deal ...

FY’24 results showcase growth potential with 12% IRR, strategic acquisitions, and undervalued stock. Read more on TMO stock ...

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data ...

Valued at a market cap of $200 billion, Thermo Fisher Scientific Inc. (TMO) is a Massachusetts-based powerhouse in scientific ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Explore Thermo Fisher Scientific Inc.'s valuation, modest growth challenges, and recent M&A moves. Click for my updated look ...

Once the transaction closes, Solventum's Purification & Filtration business will become part of Thermo Fisher's Life Sciences Solutions segment. Solventum's Purification & Filtration, as part of ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...

Thermo Fisher Scientific Inc. is the world leader ... Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their ...

Once the transaction closes, Solventum’s Purification & Filtration business will become part of Thermo Fisher's Life Sciences Solutions segment. Solventum’s Purification & Filtration ...